What Rocket Lab Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 35 | 226 |
| Total trades | 40 | 253 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 682,374 | 6,962,733 |
| Disposed | 813,735 | 9,578,082 |
| Net activity | −131,361 | −2,615,349 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Spice Adam C. | Chief Financial Officer | Nov 02 | Disclosed 10b5-1 sale · S | −6,706 | $54.78 | −$367K | 1,155,967 |
| Spice Adam C. | Chief Financial Officer | Nov 02 | Disclosed 10b5-1 sale · S | −37,950 | $54.07 | −$2.05M | 1,162,673 |
| Spice Adam C. | Chief Financial Officer | Nov 02 | Disclosed 10b5-1 sale · S | −33,681 | $53.29 | −$1.79M | 1,200,623 |
| Spice Adam C. | Chief Financial Officer | Nov 02 | Disclosed 10b5-1 sale · S | −14,266 | $52.26 | −$746K | 1,234,304 |
| Spice Adam C. | Chief Financial Officer | Nov 02 | Disclosed 10b5-1 sale · S | −47,554 | $51.28 | −$2.44M | 1,248,570 |
| Spice Adam C. | Chief Financial Officer | Nov 02 | Exercise / conversion · M | +140,157 | $1.09 | +$153K | 1,296,124 |
| Armagno Nina | Director | Nov 02 | Disclosed 10b5-1 sale · S | −100 | $55.01 | −$5.5K | 100,496 |
| Armagno Nina | Director | Nov 02 | Disclosed 10b5-1 sale · S | −2,300 | $54.34 | −$125K | 100,596 |
| Armagno Nina | Director | Nov 02 | Disclosed 10b5-1 sale · S | −3,000 | $53.55 | −$161K | 102,896 |
| Armagno Nina | Director | Nov 02 | Disclosed 10b5-1 sale · S | −1,500 | $52.63 | −$78.9K | 105,896 |
| Armagno Nina | Director | Nov 02 | Disclosed 10b5-1 sale · S | −4,026 | $51.31 | −$207K | 107,396 |
| Spice Adam C. | Chief Financial Officer | Oct 01 | Disclosed 10b5-1 sale · S | −15,200 | $71.79 | −$1.09M | 1,155,967 |
| Spice Adam C. | Chief Financial Officer | Oct 01 | Disclosed 10b5-1 sale · S | −85,288 | $70.89 | −$6.05M | 1,171,167 |
| Spice Adam C. | Chief Financial Officer | Oct 01 | Disclosed 10b5-1 sale · S | −39,669 | $70.28 | −$2.79M | 1,256,455 |
| Spice Adam C. | Chief Financial Officer | Oct 01 | Exercise / conversion · M | +140,157 | $1.09 | +$153K | 1,296,124 |
| Spice Adam C. | Chief Financial Officer | Sep 02 | Disclosed 10b5-1 sale · S | −72,900 | $62.97 | −$4.59M | 1,155,967 |
| Spice Adam C. | Chief Financial Officer | Sep 02 | Disclosed 10b5-1 sale · S | −67,257 | $62.26 | −$4.19M | 1,228,867 |
| Spice Adam C. | Chief Financial Officer | Sep 02 | Exercise / conversion · M | +140,157 | $1.09 | +$153K | 1,296,124 |
| Saintil Merline | Director | Aug 31 | Gift · G | +261,903 | — | — | 261,903 |
| Saintil Merline | Director | Aug 31 | Gift · G | −261,903 | — | — | 2,482 |
Loading...